Redox reactions of the α-Synuclein-Cu2+ complex and their effects on neuronal cell viability

Biochemistry

Volumn 49, Issue 37, 2010, Pages 8134-8142

  Wang, Chengshan ^a   Liu, Lin ^a   Zhang, Lin ^a   Peng, Yong ^a   Zhou, Feimeng ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACIDS; CELLULAR REDOX; DIRECT OXIDATION; ELECTROSPRAYS; IN-VITRO; N-TERMINALS; NEUROBLASTOMAS; NEURODEGENERATIVE DISEASE; NEURONAL CELL; PARKINSONS DISEASE; PRESYNAPTIC; PROTEINS/PEPTIDES; REDOX CYCLES; REDOX POTENTIALS; REDOX-ACTIVE METALS; SYNUCLEIN;

BRAIN; COPPER COMPOUNDS; KETONES; MASS SPECTROMETRY; METALS; ORGANIC ACIDS; OXIDATIVE STRESS; SPECTROELECTROCHEMISTRY;

REDOX REACTIONS;

ALPHA SYNUCLEIN; ASCORBIC ACID; COPPER; DOPAMINE; OXYGEN; HYDROGEN PEROXIDE; PEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL VIABILITY; ELECTROSPRAY MASS SPECTROMETRY; NERVE CELL; NEUROBLASTOMA CELL; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BINDING; CELL SURVIVAL; CHEMISTRY; HUMAN; METABOLISM; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOLOGY;

ALPHA-SYNUCLEIN; ASCORBIC ACID; CELL SURVIVAL; COPPER; DOPAMINE; HUMANS; HYDROGEN PEROXIDE; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARKINSON DISEASE; PEPTIDES;

EID: 77956571912     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi1010909     Document Type: Article

References (71)

1. Gaggelli, E., Kozlowski, H., Valensin, D., and Valensin, G. (2006) Copper homeostasis and neurodegenerative disorders (Alzheimers, prion, and Parkinsons diseases and amyotrophic lateral sclerosis) Chem. Rev. 106, 1995-2044
2. 2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy Biochemistry 39, 13760-13771
3. Jenner, P. (2003) Oxidative stress in Parkinsons disease Ann. Neurol. 53, S26-S36
4. Varadarajan, S., Yatin, S., Aksenova, M., and Butterfield, D. A. (2000) Review: Alzheimers amyloid β-peptide-associated free radical oxidative stress and neurotoxicity J. Struct. Biol. 130, 184-208
5. Sigel, A., Sigel, H., and Sigel, R. K. O. (2006) in Metal Ions in Life Sciences, John Wiley & Sons, West Sussex.
6. Jakob-Roetne, R. and Jacobsen, H. (2009) Alzheimers disease: From pathology to therapeutic approaches Angew. Chem., Int. Ed. 48, 3030-3059
7. Schrock, D. S. and Baur, J. E. (2007) Chemical imaging with voltammetry-scanning microscopy Anal. Chem. 79, 7053-7061
8. Halliwell, B. (1992) Reactive oxygen species and the central-nervous- system J. Neurochem. 59, 1609-1623
9. Crouch, P. J., Barnham, K. J., Duce, J. A., Blake, R. E., Masters, C. L., and Trounce, I. A. (2006) Copper-dependent inhibition of cytochrome c oxidase by Aβ(1-42) requires reduced methionine at residue 35 of the Aβ peptide J. Neurochem. 99, 226-236
10. Crouch, P. J., Blake, R., Duce, J. A., Ciccotosto, G. D., Li, Q., Barnham, K. J., Curtain, C. C., Cherny, R. A., Cappai, R., Dyrks, T., Masters, C. L., and Trounce, I. A. (2005) Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β(1-42) J. Neurosci. 25, 672-679
11. Zhu, M., Qin, Z., Hu, D., Munishkina, L. A., and Fink, A. L. (2006) α-Synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles Biochemistry 45, 8135-8142
12. Jiang, D., Men, L., Wang, J., Zhang, Y., Chickenyen, S., Wang, Y., and Zhou, F. (2007) Redox reactions of copper complexes formed with different β-amyloid peptides and their neuropathalogical relevance Biochemistry 46, 9270-9282
13. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998) Copper, iron and zinc in Alzheimers disease senile plaques J. Neurol. Sci. 158, 47-52
14. 2+ in a mononuclear metal ion binding site J. Am. Chem. Soc. 126, 13534-13538
15. Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E., and Bush, A. I. (1999) The Aβ peptide of Alzheimers disease directly produces hydrogen peroxide through metal ion reduction Biochemistry 38, 7609-7614
16. Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Saunders, A. J., Lim, J., Moir, R. D., Glabe, C., Bowden, E. F., Masters, C. L., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (1999) Cu(II) potentiation of Alzheimer Aβ neurotoxicity - Correlation with cell-free hydrogen peroxide production and metal reduction J. Biol. Chem. 274, 37111-37116
17. Hewitt, N. and Rauk, A. (2009) Mechanism of hydrogen peroxide production by copper-bound amyloid beta peptide: A theoretical study J. Phys. Chem. B 113, 1202-1209
18. Barb, W. G., Baxendale, J. H., George, P., and Hargrave, K. R. (1951) Reactions of ferrous and ferric ions with hydrogen peroxide. Part I - The ferrous ion reaction Trans. Faraday Soc. 47, 462-500
19. Jiang, D., Li, X., Liu, L., Yagnik, G. B., and Zhou, F. (2010) Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-β complexes and aggregates J. Phys. Chem. B 114, 4896-4903
20. Smith, M. A., Harris, P. L. R., Sayre, L. M., and Perry, G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc. Natl. Acad. Sci. U.S.A. 94, 9866-9868
21. Dong, J., Atwood, C. S., Anderson, V. E., Siedlak, S. L., Smith, M. A., Perry, G., and Carey, P. R. (2003) Metal binding and oxidation of amyloid-β within isolated senile plaque cores: Raman microscopic evidence Biochemistry 42, 2768-2773
22. Baruch-Suchodolsky, R. and Fischer, B. (2008) Soluble amyloid β(1-28)-copper(I)/copper(II)/iron(II) complexes are potent antioxidants in cell-free system Biochemistry 47, 7796-7806
23. Baruch-Suchodolsky, R. and Fischer, B. (2009) Aβ1-40, soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems Biochemistry 49, 4354-4370
24. Guilloreau, L., Combalbert, S., Sournia-Saquet, A., Mazarguil, H., and Faller, P. (2007) Rodox chemistry of copper-amyloid-β: The generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state ChemBioChem 8, 1317-1325
25. Gibb, W. R. G. and Lees, A. J. (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinsons disease J. Neurol. Neurosurg. Psych. 51, 745-752
26. Forno, L. S. (1996) Neuropathology of Parkinsons disease J. Neuropathol. Exp. Neurol. 55, 259-272
27. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998) α-synuclein in filamentous inclusions of Lewy bodies from Parkinsons disease and dementia with Lewy bodies Proc. Natl. Acad. Sci. U.S.A. 95, 6469-6473 (Pubitemid 28249037)
28. Spillantini, M. G., Schmidt, M. L., Lee, V. M. Y., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997) α-synuclein in Lewy bodies Nature 388, 839-840
29. Fink, A. L. (2006) The aggregation and fibrillation of α-synuclein Acc. Chem. Res. 39, 628-634
30. Binolfi, A., Lamberto, G. R., Duran, R., Quintanar, L., Bertoncini, C. W., Souza, J. M., Cervenansky, C., Zweckstetter, M., Griesinger, C., and Fernandez, C. O. (2008) Site-specific interactions of Cu(II) with alpha and β-synuclein: Bridging the molecular gap between metal binding and aggregation J. Am. Chem. Soc. 130, 11801-11812
31. Jackson, M. S. and Lee, J. C. (2009) Identification of the minimal copper(II)-binding α-synuclein sequence Inorg. Chem. 48, 9303-9307
32. Kim, K. S., Choi, S. Y., Kwon, H. Y., Woo, M. H., Kang, T. C., and Kang, J. H. (2002) Aggregation of α-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system Free Radical Biol. Med. 32, 544-540
33. Ceballos, I., Lafon, M., Javoyagid, F., Hirsch, E., Nicole, A., Sinet, P. M., and Agid, Y. (1990) Superoxide dismutase and Parkinsons disease Lancet 335, 1035-1036
34. Dexter, D. T., Carayon, A., Javoyagid, F., Agid, Y., Wells, F. R., Daniel, S. E., Lees, A. J., Jenner, P., and Marsden, C. D. (1991) Alterations in the levels of iron, ferritin and other trace-metals in Parkinsons disease and other neurodegenerative diseases affecting the basal ganglia Brain 114, 1953-1975
35. Pall, H. S., Blake, D. R., Gutteridge, J. M., Williams, A. C., Lunec, J., Hall, M., and Taylor, A. (1987) Raised cerebrospinal-fluid copper concentration in Parkinsons disease Lancet 2, 238-241
36. Riederer, P., Sofic, E., Rausch, W. D., Schmidt, B., Reynolds, G. P., Jellinger, K., and Youdim, M. B. H. (1989) Transition-metals, ferritin, glutathione, and ascorbic-acid in Parkinsonian brains J. Neurochem. 52, 515-520
37. Brown, D. R. (2009) Metal binding to alpha-synuclein peptides and its contribution to toxicity Biochem. Biophys. Res. Commun. 380, 377-381
38. Caughey, B. and Lansbury, P. T. (2003) Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders Annu. Rev. Neurosci. 26, 267-298
39. Paik, S. R., Shin, H. J., Lee, J. H., Chang, C. S., and Kim, J. (1999) Copper(II)-induced self-oligomerization of α-synuclein Biochem. J. 340, 821-828
40. Palecek, E., Ostatna, V., Masarik, M., Bertoncini, C. W., and Jovin, T. M. (2008) Changes in interfacial properties of alpha-synuclein preceding its aggregation Analyst 133, 76-84
41. Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoyagid, F., Jenner, P., and Marsden, C. D. (1994) Alterations in glutathione levels in Parkinsons disease and other neurodegenerative disorders affecting basal ganglia Ann. Neurol. 36, 348-355
42. Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., and Halliwell, B. (1997) A generalised increase in protein carbonyls in the brain in Parkinsons but not incidental Lewy body disease J. Neurochem. 69, 1326-1329
43. Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., and Halliwell, B. (1997) Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra J. Neurochem. 69, 1196-1203
44. Golts, N., Snyder, H., Frasier, M., Theisler, C., Choi, P., and Wolozin, B. (2002) Magnesium inhibits spontaneous and iron-induced aggregation of α-synuclein J. Biol. Chem. 277, 16116-16123
45. 2+ and biological implications of the resultant complexes J. Inorg. Biochem. 104, 365-370
46. Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., Kleinman, M. H., Turro, N., Krantz, D., Edwards, R. H., Greene, L. A., and Zecca, L. (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles Proc. Natl. Acad. Sci. U.S.A. 97, 11869-11874
47. Dexter, D. T., Sian, J., Rose, S., Hindmarsh, J. G., Mann, V. M., Cooper, J. M., Wells, F. R., Daniel, S. E., Lees, A. J., Schapira, A. H. V., Jenner, P., and Marsen, C. D. (1994) Indexes of oxidative stress and Mitochondrial function in individuals with incidental Lewy body disease Ann. Neurol. 35, 38-44
48. Ding, T., Lee, S. J., Rochet, J. C., and Lansbury, P. T. (2002) Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes Biochemistry 41, 10209-10217
49. http://www.basinc.com/mans/PE-man.pdf (accessed July 5, 2010).
50. Binolfi, A., Rasia, R. M., Bertoncini, C. W., Ceolin, M., Zweckstetter, M., Griesinger, C., Jovin, T. M., and Fernandez, C. O. (2006) Interaction of α-synuclein with divalent metal ions reveals key differences: A link between structure, binding specificity and fibrillation enhancement J. Am. Chem. Soc. 128, 9893-9901
51. Rasia, R. M., Bertoncini, C. W., Marsh, D., Hoyer, W., Cherny, D., Zweckstetter, M., Griesinger, C., Jovin, T. M., and Fernandez, C. O. (2005) Structural characterization of copper(II) binding to α-synuclein: Insights into the bioinorganic chemistry of Parkinsons disease Proc. Natl. Acad. Sci. U.S.A. 102, 4294-4299
52. 2 reduction by scanning electrochemical microscopy J. Am. Chem. Soc. 127, 17576-17577
53. Scarpa, M., Vianello, F., Signor, L., Zennaro, L., and Rigo, A. (1996) Ascorbate oxidation catalyzed by bis(histidine)copper(II) Inorg. Chem. 35, 5201-5206
54. Conway, B. E. (1969) Electrochemical Data, Greenwood Press, New York.
55. Bard, A. J. and Faulkner, L. R. (2001) Electrochemical Methods. Fundamentals and Applications, John Wiley & Sons, New York.
56. Guzman Barron, E. S., Demeio, R. H., and Klemperer, F. (1936) Studies on biological oxidations. V. Copper and hemochromogens as catalysts for the oxidation of ascorbic acid. The mechanism of the oxidation J. Biol. Chem. 112, 925-940
57. Rice, M. E. and RussoMenna, I. (1998) Differential compartmentalization of brain ascorbate and glutathione between neurons and glia Neuroscience 82, 1213-1223
58. Greenwald, R. A. (1990) Superoxide-dismutase and catalase as therapeutic agents for human diseases, a critical review Free Radical Biol. Med. 8, 201-209
59. Atwooda, C. S., Obrenovicha, M. E., Liu, T., Chan, H., Perry, G., Smith, M. A., and Martins, R. N. (2003) Amyloid-β: A chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β Brain Res. Rev. 43, 1-16
60. Uversky, V. N., Li, J., and Fink, A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein: A possible molecular link between Parkinsons disease and heavy metal exposure J. Biol. Chem. 276, 44284-44296
61. Dryhurst, G., Kadish, K. M., Scheller, F., and Renneberg, R. (1982) Biological Electrochemistry, Vol. 1, Academic Press, New York and London.
62. Rolett, E. L., Azzawi, A., Liu, K. J., Yongbi, M. N., Swartz, H. M., and Dunn, J. F. (2000) Critical oxygen tension in rat brain: A combined P-31-NMR and EPR oximetry study Am. J. Physiol. 279, 9-16
63. Crichton, R. (2009) Iron Metabolism from Molecular Mechanisms to Clinical Consequences, 3 rd ed., pp 224 - 226, John Wiley & Sons, West Sussex.
64. Tohgi, H., Abe, T., Takahashi, S., Takahashi, J., and Hamato, H. (1993) Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal-fluid of patients with Parkinsons disease, and their changes after l -dopa administration Neurosci. Lett. 159, 135-138
65. Kawashima, T., Ohkubo, K., and Fukuzumi, S. (2010) Radical scavenging reactivity of catecholamine neurotransmitters and the inhibition effect for DNA cleavage J. Phys. Chem. B 114, 675-680
66. Varadarajan, S., Kanski, J., Aksenova, M., Lauderback, C., and Butterfield, D. A. (2001) Different mechanisms of oxidative stress and neurotoxicity for Alzheimers Aβ(1-42) and Aβ(25-35) J. Am. Chem. Soc. 123, 5625-5631
67. 2O J. Inorg. Biochem. 55, 87-99
68. Kostka, M., Hogen, T., Danzer, K. M., Levin, J., Habeck, M., Wirth, A., Wagner, R., Glabe, C. G., Finger, S., Heinzelmann, U., Garidel, P., Duan, W., Ross, C. A., Kretzschmar, H., and Giese, A. (2008) Single particle characterization of iron-induced pore-forming α-synuclein oligomers J. Biol. Chem. 283, 10992-11003
69. Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B., and Kostka, M. (2007) Different species of α-synuclein oligomers induce calcium influx and seeding J. Neurosci. 27, 9220-9232
70. Wright, J. A., Wang, X., and Brown, D. R. (2009) Unique copper-induced oligomers mediate alpha-synuclein toxicity FASEB J. 23, 2384-2393
71. Kheterpal, I., Williams, A., Murphy, C., Bledsoe, B., and Wetzel, R. (2001) Structural features of the Aβ amyloid fibril elucidated by limited proteolysis Biochemistry 40, 11757-11767